Board to consider Dividend
Sicagen India Ltd has informed BSE that the meeting of the Board of Directors of the Company has been scheduled to be held on May 17, 2017, inter alia, to consider the following:1. Audited Annual Accounts of the Company for the year ended March 31, 2017.2. Audited Financial Results (Standalone & Consolidated Results) for the quarter and year ended March 31, 2017.3. Recommendation of equity dividend for the year 2016-17. Board Meeting On 17.05.2017
The meeting of the Board of Directors of the Company has been scheduled to be held on Wednesday, the 17th May 2017 at 11.15 a.m., inter alia, to consider the following :- Audited Annual Accounts of the Company for the year ended 31st March 2017. Audited Financial Results (Standalone & Consolidated Results) for the quarter and year ended 31st March 2017. Recommendation of equity dividend for the year 2016-17. Shareholding for the Period Ended March 31, 2017
Sicagen India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click here Standalone & Consolidated Financial Results, Limited Review Report for December 31, 2016
Sicagen India Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20162. Consolidated Financial Results for the period ended December 31, 20163. Standalone Limited Review for the period ended December 31, 20164. Consolidated Limited Review for the period ended December 31, 2016 Board Meeting Intimation for Results
Sicagen India Ltd has informed BSE that the meeting of the Board of Directors of the Company has been scheduled to be held on January 30, 2017, inter alia, to consider & approve the unaudited financial results of the Company for the quarter ended December 31, 2016. Shareholding for the Period Ended December 31, 2016
Sicagen India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click here Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
Sicagen India Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Standalone & Consolidated Financial Results, Limited Review Report for September 30, 2016
Sicagen India Ltd has informed BSE about : 1. Standalone Financial Results for the period ended September 30, 20162. Consolidated Financial Results for the period ended September 30, 20163. Standalone Limited Review for the period ended September 30, 20164. Consolidated Limited Review for the period ended September 30, 2016 Reconstitution of Audit Committee
Sicagen India Ltd has informed BSE regarding "Reconstitution of Audit Committee". Board Meeting Intimation for Results
Sicagen India Ltd has informed BSE that the meeting of the Board of Directors of the Company has been scheduled to be held on November 10, 2016, inter alia, to consider & approve the unaudited financial results of the Company for the quarter and half year ended September 30, 2016.